ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1734

CXCR5+ CD4 T Cells Signature Differentiates Takayasu Arteritis from Giant Cell Arteritis

Anne-Claire Desbois1, Valentin Quiniou2, Patrick Bruneval3, Nicolas Derian2, Anna Maciejewski-Duval2, Marlène Garrido4, Cloé Comarmond5, Jacques Pouchot6, Michelle Rosenzwajg2, David Klatzmann2, Patrice Cacoub7 and David Saadoun8, 1Hôpital Pitié-Salpêtrière, Internal Medicine and Clinical Immunology, Paris, France, 2GHPS, Paris, France, 3HEGP, Paris, France, 4I3 laboratory, Pitié-Salpétrière, Paris, France, 5DHU 2iB Internal Medicine Referal Center for Autoimmune diseases Pitie Hospital, Paris, France, 6Internal Medicine Department, European Hospital Georges Pompidou, Paris, France, 7Department of Internal Medicine and Clinical Immunology, Groupe Hospitalier Pitié-Salpêtrière, Paris, France, 8Sorbonne Universités, UPMC Univ Paris 06, UMR 7211, and Inflammation-Immunopathology-Biotherapy Department (DHU i2B), F-75005, Paris, France; INSERM, UMR_S 959, F-75013, Paris, France; CNRS, FRE3632, F-75005, Paris, France; AP-HP, Groupe Hospitalier, Paris, France

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: giant cell arteritis, T cells, takayasu arteritis and vasculitis

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 6, 2017

Title: T Cell Biology and Targets in Autoimmune Disease Poster I

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: To compare microarray gene analysis of patients with Giant cell arteritis to patients with Takayasu arteritis.

Methods: We performed comparative microarray gene analysis of purified CD4+ T cells of TA (n=14) and GCA (n=15) patients.

Results: We found that purified CD4+ T cells of GCA and TA patients exhibit distinct RNA signatures. Sixty-seven genes were differentially expressed, among which CXCR5, CCR6 and CCL20 were shown to be significantly up-regulated in CD4+ T cells of TA patients as compared to those of GCA. Flow cytometry analysis confirmed that CXCR5+ CD4+ cells, defined as T Follicular Helper cells (TFH), were significantly higher in TA patients as compared to GCA and healthy donors (HD) [median proportion of CXCR5+ CD4+ T cells of 15.4 (10;30.8) in TA versus 5.3 (1.4; 12.2) in GCA (p<0.0001) and 9.7 (5.6; 12.5) in HD (p=0.0001)]. Among TFH subpopulations, TFH-17 (defined as CCR6+ CXCR5+ CD4+ T cells) was specifically increased in TA [4.52 (1.07; 13.35) in TA vs 0.69 (0.13; 2.16) in GCA (p=0.0001) and 2.3 (0.3; 4.2) in HD (p=0.02)]. The analysis of inflammatory aortic lesions revealed the presence of tertiary lymphoid structures, composed of CXCR5+, CD4+, PD-1 and CD-20 cells in TA whereas such organized inflammatory infiltrates were uncommon in GCA aortic lesions. We demonstrated an increased peripheral B cell immune response in TA, as the number of peripheral B cells is increased in TA compared to GCA. CXCR5+ CD4+ T cells in TA patients have specific characteristics of TFH, as they help B cells to differentiate into memory B cells, to proliferate and to secrete IgG.

Conclusion: Patients with TA differ from patients with GCA in microarray gene analysis of purified CD4+ T cells. Our data provide evidence of the critical role of TFH in pathogenesis of inflammatory lesions in TA and suggest the role of antigenic trigger.


Disclosure: A. C. Desbois, None; V. Quiniou, None; P. Bruneval, None; N. Derian, None; A. Maciejewski-Duval, None; M. Garrido, None; C. Comarmond, None; J. Pouchot, None; M. Rosenzwajg, None; D. Klatzmann, None; P. Cacoub, None; D. Saadoun, None.

To cite this abstract in AMA style:

Desbois AC, Quiniou V, Bruneval P, Derian N, Maciejewski-Duval A, Garrido M, Comarmond C, Pouchot J, Rosenzwajg M, Klatzmann D, Cacoub P, Saadoun D. CXCR5+ CD4 T Cells Signature Differentiates Takayasu Arteritis from Giant Cell Arteritis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/cxcr5-cd4-t-cells-signature-differentiates-takayasu-arteritis-from-giant-cell-arteritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/cxcr5-cd4-t-cells-signature-differentiates-takayasu-arteritis-from-giant-cell-arteritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology